Representation and distribution for the former Yugoslavia countries
RIEMSER Pharma GmbH
RIEMSER Pharma GmbH is, in the period only a few years, grown into one of the largest manufacturers and inventors of pharmaceutical products in eastern Germany. RIEMSER Pharma GmbH exports to over than 80 countries, including China, Russia and the United States, and the work performed to abroad makes up more than 40 percent of total sales. Riemser has a very diversified portfolio, which includes the fields of human, veterinary and dental products.
Representation and distribution for the Bosnia and Herzegovina
Johnson&Johnson HCP & Pharmaceuticals
The company operates through three sectors. The main sector is an innovative medicines - psychiatry, oncology, neurology, nephrology, pain management, reproductive health / contraception, AIDS, fungal diseases .. and other sectors engaged in research and production of skin care products, nursing mothers and children, women's hygiene...
Indivior began with the goal of addressing the lack of treatment for the worldwide problem of addiction. In 1994, RB established the Buprenorphine Business Group, to which Indivior can trace its history of over 20 years. The buprenorphine Business Group focused on developing buprenorphine for the treatment of opioid dependence. Even though it was an area of business that was unproven, we believed we could make a measurable difference in the lives of patients all over the world. Through a grassroots effort, we’ve partnered with and educated governments, policy makers, payers, and heathcare professionals about diseases of addiction and the value of alternative treatment options (including office-based treatment). We’ve also worked diligently and strategically to identify and address the unmet treatment needs of patients. By creating a marketplace environment of increased acceptance, we have provided an estimated 5 million patients effective treatment options with SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII), SUBOXONE® (buprenorphine and naloxone) Sublingual Tablet (CIII), and SUBUTEX® (buprenorphine) Sublingual Tablet (CIII) in the US alone, always keeping our focus on the individual.
We’re proud of our history but, more than that, we’re excited about our future.
QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. QIAGEN currently maintains about 35 subsidiaries in over 25 countries and has a global network of distribution partners in more than 60 countries
TARCHOMINSKIE ZAKLADY FARMA CEUTYCZNE „POLFA“ SPOLKA AKCYJNA
Polfa Tarchomin SA is a leader in the field of anti-infective drugs. In the group of insulin, psychotropic drugs and dermatological preparations has significant market position. Products are available in different forms and doses for optimal medical therapy and minimal side effects to the patient.
ERIS Pharma is an Australian pharmaceutical company which aim is to bring a range of Australian TGA approved health products to the world market. ERIS Pharma has quickly become a recognized and accepted brand, and it shows the dynamic growth across the MENA region, CIS countries and the Balkans.
Established in 1935, the company was privatized in 2000 with the participation of exclusively of Polish capital, which, with a huge investment, begun dynamic development. Today it is an important international pharmaceutical company, which is present in the markets of Central and Eastern Europe, the Caucasus and Central Asia. Polpharma is among the top 20 generic drug manufacturers in the world, with sales of $ 1 billion annually.
Bioton is a biotechnology company engaged in the production of recombinant human insulin. Bioton aims to develop strategic objectives to protect the health of patients and improving their quality of life through participation in research projects and the development of innovative and clinically relevant medical products, including biologicals.
Berkoilac the Turkish pharmaceutical company with a broad product range. Berko Pharmaceuticals is a new production plant in Istanbul, designed for the manufacturing of licensed drugs under the auspices of the Ministry of Health. Possessing an indoor facility of 5000 m2 in accordance with all relevant requirements of GMP.
Biopharma is a Turkish pharmaceutical company engaged in the production of generic drugs by world standards while preserving the environment and awareness of social responsibility.
Deva is a Turkish company founded in 1958 years. The main business scope covers manufacture and marketing of medicines for human use. In 2012 production of Deva Holding is audited by the German Ministry of Health and received approval in accordance with EU GMP.
Sopharma is one of the largest drug manufacturers in Bulgaria. Nomenclature of the company exceeds 170 drugs, including almost all the pharmacotherapeutic group. The primary mission of Sopharma is the production of high - quality, affordable and effective medical products that will guarantee healthy lifes of consumers.
Azevedo was founded in 1775 and since then, until today, through more than two centuries, is located at the top pharmaceutical companies in Portugal. Aware of its long history every day strive to be better in order to retain the trust of their rightful partners.
Mustafa Nevzat is a leading turkey on pharmaceutical company founded in 1923 years. Mustafa Nevzat owns modern manufacturing facilities with 1,400 employees and skilled workers. Today, the manufacturer of one of the leading manufacturers of finished drugs and pharmaceutical raw materials. In November 2006 the facilities for raw materials and finished products are audited by the FDA and have received the approval of the same. Mustafa Nevzat has received FDA approval for finished products as one of the first Turkish pharmaceutical manufacturers.
Since 2001, the company’s core business has been development, design and production of generic drugs in different pharmaceutical therapeutic categories, in oral dosage forms: tablets, capsules and oral solutions, as well as topical medicaments (creams and ointments).
Polifarma is founded in 1986, in the leadership of mr.ph Necdet Nuri Kumurulu and became one of the Turkey's exceptional companies in the field. Polifarma produces all of it's products in Turkey's most comprehensive and modern modern Parenteral Solution Production Facility using advanced tehnology, and in compliance with the norms of C-GMP. Trough it history Polifarma has advanced to a major producer of very large portofolio of glass, PVC and PP parenteral solutions and it is one of the largest product supplier of Turkish market.